Last close · 16 Oct 2026
Rs 31.99 +0.22%
Annual · FY2016 – FY2026
Liven Pharma Limited (LIVEN) cash flow statement
Operating activities generated Rs 9.0 mn of cash in FY2026 (Jul 2025 – Jun 2026). Capital expenditure was Rs 29.7 mn, leaving free cash flow of -Rs 20.7 mn. Overall, cash increased by Rs 10.4 mn.
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 * Jul 2024 – Jun 2025 | FY2024 * Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||||
| Profit (cash-flow starting line, as reported) | (66.3) | (492.2) | (13.8) | (15.2) | (17.5) | ||||||
| Depreciation & amortisation | 30.8 | 27.6 | 11.8 | 13.1 | 14.6 | ||||||
| Net cash from operating activities | 9.0 | (1.7) | (0.9) | (2.3) | (2.3) | ||||||
| Investing activities | |||||||||||
| Capital expenditure | (29.7) | (32.8) | — | — | — | ||||||
| Net cash from investing activities | (185.8) | (32.8) | — | — | — | ||||||
| Financing activities | |||||||||||
| Borrowings raised / (repaid) | (4.1) | 17.5 | 0.9 | 2.3 | 2.2 | ||||||
| Net cash from financing activities | 187.2 | 17.5 | 0.9 | 2.3 | 2.2 | ||||||
| Net change in cash | 10.4 | (17.1) | 0.0 | 0.0 | (0.0) | ||||||
| Key figures | |||||||||||
| Free cash flow (operating cash flow − capex) | (20.7) | (34.6) | — | — | — | ||||||
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 * Jul 2024 – Jun 2025 | FY2024 * Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||||
| Profit (cash-flow starting line, as reported) | — | — | — | — | — | ||||||
| Depreciation & amortisation | +11.6% | +134.4% | -10.0% | -10.0% | -9.5% | ||||||
| Net cash from operating activities | — | — | — | — | — | ||||||
| Investing activities | |||||||||||
| Capital expenditure | -9.7% | — | — | — | — | ||||||
| Net cash from investing activities | — | — | — | — | — | ||||||
| Financing activities | |||||||||||
| Borrowings raised / (repaid) | -123.5% | +1,863.1% | -60.8% | +1.2% | -67.0% | ||||||
| Net cash from financing activities | +972.3% | +1,863.1% | -60.8% | +1.2% | -67.0% | ||||||
| Net change in cash | — | -155,050.8% | +19,930.9% | — | — | ||||||
| Key figures | |||||||||||
| Free cash flow (operating cash flow − capex) | — | — | — | — | — | ||||||
Change against the previous fiscal year; shown when the earlier figure is positive.
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. * Figures in this period do not fully reconcile in the source data (hover the * for details). Updated 16 Oct 2026.
All reported line items 62
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 |
|---|---|---|---|---|---|
| Profit/(Loss) - Starting Line - Cash Flow | (66.3) | (492.2) | (13.8) | (15.2) | (17.5) |
| Non-cash Items & Reconciliation Adjustments - Cash Flow | 82.2 | 473.1 | 11.8 | 13.1 | 14.6 |
| Income Tax Expense - Cash Flow - to Reconcile | — | — | — | — | — |
| Other Non-Cash Items & Reconciliation Adjustments - Cash Flow - to Reconcile | 53.5 | 444.7 | 0.0 | 0.0 | 0.0 |
| Financial Income/(Expense) - Cash Flow - to Reconcile | 2.5 | 0.8 | — | — | — |
| Depreciation, Depletion & Amortization including Impairment - Cash Flow - to Reconcile | 30.8 | 27.6 | 11.8 | 13.1 | 14.6 |
| Depreciation & Depletion - Property, Plant & Equipment - Cash Flow - to Reconcile | 27.2 | 24.7 | 11.8 | 13.1 | 14.6 |
| Amortization - Intangible Assets & Deferred Charges - Cash Flow - to Reconcile | 3.6 | 3.0 | — | — | — |
| Assets Sale - Gain/(Loss) - Cash Flow - to Reconcile | (4.7) | — | — | — | — |
| Income Taxes - Paid/(Reimbursed) - Cash Flow | 0.7 | — | — | — | — |
| Interest Paid - Cash | 2.6 | 0.5 | — | — | — |
| Cash Flow from Operating Activities before Changes in Working Capital | 12.6 | (19.6) | (2.0) | (2.1) | (3.0) |
| Working Capital - Increase/(Decrease) - Cash Flow | (3.6) | 17.8 | 1.1 | (0.1) | 0.7 |
| Accounts Receivables - Decrease/(Increase) - Cash Flow | (13.3) | (21.5) | — | 0.0 | (0.1) |
| Inventories - Decrease/(Increase) - Cash Flow | (6.3) | 0.5 | — | — | — |
| Other Assets - Decrease/(Increase) - Cash Flow | (4.6) | (0.5) | — | 0.0 | 0.4 |
| Accrued Expenses - Increase/(Decrease) - Cash Flow | — | — | — | — | — |
| Accounts Payable - Increase/(Decrease) - Cash Flow | 20.6 | 39.4 | 1.1 | (0.1) | 0.4 |
| Net Cash Flow from Operating Activities | 9.0 | (1.7) | (0.9) | (2.3) | (2.3) |
| Capital Expenditures - Net - Cash Flow | 22.5 | 32.8 | — | — | — |
| Property, Plant & Equipment - Purchased/(Sold) - Net - Cash Flow | 22.5 | 22.8 | — | — | — |
| Property, Plant & Equipment - Purchased - Cash Flow | 29.7 | 22.8 | — | — | — |
| Property, Plant & Equipment Sold - Cash Flow | 7.1 | — | — | — | — |
| Intangible Assets - Purchased/(Sold) - Net - Total - Cash Flow | 0.0 | 10.0 | — | — | — |
| Intangible Assets - Purchased/Acquired - Cash Flow | 0.0 | 10.0 | — | — | — |
| Capital Expenditures - Total | 29.7 | 32.8 | — | — | — |
| Investments excluding Loans - Decrease/(Increase) - Cash Flow | (163.3) | — | — | — | — |
| Investment Securities - Unclassified - Sold/(Purchased) - Net - Total - Cash Flow | (163.3) | — | — | — | — |
| Investment Securities - Sold/Matured - Unclassified - Cash Flow | 483.3 | — | — | — | — |
| Investment Securities - Purchased - Unclassified - Cash Flow | 646.6 | — | — | — | — |
| Other Investing Cash Flow - Decrease/(Increase) | — | — | — | — | — |
| Net Cash Flow from Investing Activities | (185.8) | (32.8) | — | — | — |
| Stock - Total - Issuance/(Retirement) - Net - Cash Flow | 200.0 | — | — | — | — |
| Stock - Issuance/(Retirement) - Net - Excluding Options/Warrants - Cash Flow | 200.0 | — | — | — | — |
| Stock - Common - Issuance/(Retirement) - Net - Cash Flow | 200.0 | — | — | — | — |
| Stock - Common - Issued/Sold - Cash Flow | 200.0 | — | — | — | — |
| Debt - Long-Term & Short-Term - Issuance/(Retirement) - Total - Cash Flow | (4.1) | 17.5 | 0.9 | 2.3 | 2.2 |
| Debt - Issued/(Reduced) - Long-Term & Short-Term - Cash Flow | (0.4) | — | — | — | — |
| Debt - Reduced - Long-Term & Short-Term - Cash Flow | 0.4 | — | — | — | — |
| Debt - Issued/(Reduced) - Short-Term - Total - Cash Flow | (0.4) | 12.6 | 0.9 | 2.3 | 2.2 |
| Debt - Issued - Short-Term - Cash Flow | 92.4 | 168.7 | 0.9 | 2.3 | 2.2 |
| Debt - Reduced - Short-Term - Cash Flow | 92.8 | 156.1 | — | — | — |
| Debt - Issued/Reduced - Long-Term - Cash Flow | (3.3) | 4.9 | — | — | — |
| Lease liabilities - Issued/(Reduced) - Cash Flow | (0.7) | (1.4) | — | — | — |
| Debt - Issued - Long-Term - Cash Flow | 0.0 | 6.7 | — | — | — |
| Debt - Reduced - Long-Term - Cash Flow | 3.3 | 1.8 | — | — | — |
| Lease liabilities - Reduced - Cash flow represents cash outflow due to the repayment of lease liability/debt of the company. It includes finance leases, capitalized lease, and hire-purchase agreement. Applicable to all industries. If Lease liability issue | 0.7 | 1.4 | — | — | — |
| Other Financing Cash Flow - Increase/(Decrease) | (8.7) | — | — | — | — |
| Net Cash Flow from Financing Activities | 187.2 | 17.5 | 0.9 | 2.3 | 2.2 |
| Non-Classified Cash Flows | 0.0 | 0.0 | — | — | — |
| Net Change in Cash - Total | 10.4 | (17.1) | 0.0 | 0.0 | (0.0) |
| Net Cash from Continuing Operations | 10.4 | (17.1) | 0.0 | 0.0 | (0.0) |
| Net Cash - Beginning Balance | 7.9 | 25.0 | 0.0 | 0.0 | 0.0 |
| Net Cash - Ending Balance | 18.3 | 7.9 | 0.0 | 0.0 | 0.0 |
| Income Taxes - Paid/(Reimbursed) - Cash Flow - Supplemental | 0.7 | — | — | — | — |
| Interest Paid - Cash Flow - Supplemental | 2.6 | 0.5 | — | — | — |
| CF from Optg Activities before Change in WC & Int Payments | 15.2 | (19.1) | (2.0) | (2.1) | (3.0) |
| Common Stock Buyback - Net | (200.0) | — | — | — | — |
| Depreciation, Depletion & Amortization - Cash Flow | 30.8 | 27.6 | 11.8 | 13.1 | 14.6 |
| Free Cash Flow to Equity | (17.6) | (17.1) | 0.0 | 0.0 | (0.0) |
| Free Cash Flow Net of Dividends | (20.7) | (34.6) | — | — | — |
| Free Cash Flow | (20.7) | (34.6) | — | — | — |
Every line the company reported, in the original order and wording, without regrouping or signs changed.